ACXP · Insider Trading
Acurx Pharmaceuticals, Inc. Common Stock
Every open-market purchase and sale reported by ACXP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-22 | James J. Donohue | Director | A | +2,150 deriv. | — |
| 2026-04-22 | Jack H Dean | Director | A | +2,150 deriv. | — |
| 2026-04-22 | Carl Sailer | Director | A | +2,150 deriv. | — |
| 2026-04-22 | Robert J Deluccia | Director | A | +37,100 deriv. | — |
| 2026-04-22 | Thomas L Harrison | Director | A | +2,150 deriv. | — |
| 2026-04-22 | David P Luci | President and CEO | A | +37,100 deriv. | — |
| 2026-04-22 | Robert G. Shawah | Chief Financial Officer | A | +25,900 deriv. | — |
| 2026-04-22 | Joseph C Scodari | Director | A | +2,150 deriv. | — |
| 2025-02-06 | Robert J Deluccia | Director | A | +250,000 deriv. | — |
| 2025-02-06 | Robert G. Shawah | Chief Financial Officer | A | +145,500 deriv. | — |
| 2025-02-06 | David P Luci | President and CEO | A | +250,000 deriv. | — |
| 2025-01-08 | Carl Sailer | Director | Buy | +24,631 | +$25.00K |
| 2025-01-08 | Joseph C Scodari | Director | Buy | +24,631 | +$25.00K |
| 2025-01-08 | David P Luci | President and CEO | Buy | +49,261 | +$50.00K |
| 2025-01-08 | Jack H Dean | Director | Buy | +9,852 | +$10.00K |
| 2025-01-08 | James J. Donohue | Director | Buy | +9,852 | +$10.00K |
| 2025-01-08 | Robert J Deluccia | Director | Buy | +49,261 | +$50.00K |
| 2024-06-18 | Carl Sailer | Director | A | +12,000 deriv. | — |
| 2024-06-18 | Thomas L Harrison | Director | A | +12,000 deriv. | — |
| 2024-06-18 | James J. Donohue | Director | A | +12,000 deriv. | — |
| 2024-06-18 | Joseph C Scodari | Director | A | +12,000 deriv. | — |
| 2024-06-18 | Jack H Dean | Director | A | +12,000 deriv. | — |
| 2024-04-03 | David P Luci | President and CEO | A | +250,000 deriv. | — |
| 2024-04-03 | Robert J Deluccia | Director | A | +250,000 deriv. | — |
| 2024-04-03 | Robert G. Shawah | Chief Financial Officer | A | +145,000 deriv. | — |
| 2024-01-22 | Carl Sailer | Director | M | +19,737 | +$70.07K |
| 2024-01-04 | Robert J Deluccia | Director | MIXED | −90,263 | +$70.07K |
| 2024-01-04 | David P Luci | President and CEO | M | +19,737 | +$70.07K |
| 2023-06-16 | James J. Donohue | Director | A | +10,000 deriv. | — |
| 2023-06-16 | Jack H Dean | Director | A | +10,000 deriv. | — |
| 2023-06-16 | Carl Sailer | Director | A | +10,000 deriv. | — |
| 2023-06-16 | Joseph C Scodari | Director | A | +10,000 deriv. | — |
| 2023-06-16 | Thomas L Harrison | Director | A | +10,000 deriv. | — |
| 2023-02-24 | David P Luci | President and CEO | A | +130,000 deriv. | — |
| 2023-02-24 | Robert J Deluccia | Director | A | +130,000 deriv. | — |
| 2023-02-24 | Robert G. Shawah | Chief Financial Officer | A | +75,000 deriv. | — |
| 2022-07-29 | Robert J Deluccia | Director | Buy | +19,737 | +$75.00K |
| 2022-07-29 | Carl Sailer | Director | Buy | +19,737 | +$75.00K |
| 2022-07-29 | David P Luci | President and CEO | Buy | +19,737 | +$75.00K |
| 2021-11-24 | Carl Sailer | Director | Buy | +5,161 | +$24.98K |
| 2021-11-22 | David P Luci | President and CEO | Buy | +5,200 | +$24.96K |
| 2021-11-22 | Robert J Deluccia | Director | Buy | +5,034 | +$24.67K |
| 2021-09-10 | Carl Sailer | Director | Buy | +12,500 | +$75.00K |
| 2021-07-06 | Jack H Dean | Director | A | +50,000 deriv. | — |
| 2021-07-06 | Thomas L Harrison | Director | A | +50,000 deriv. | — |
| 2021-07-06 | Robert G. Shawah | Chief Financial Officer | A | +270,000 deriv. | — |
| 2021-07-06 | David P Luci | President and CEO | A | +850,000 deriv. | — |
| 2021-07-06 | Joseph C Scodari | Director | A | +50,000 deriv. | — |
| 2021-07-06 | Robert J Deluccia | Director | A | +850,000 deriv. | — |
| 2021-07-06 | Carl Sailer | Director | A | +50,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| David P Luci | President and CEO | 55,627 | $58.96K |
| Robert J Deluccia | Director | 50,702 | $53.74K |
| Carl Sailer | Director | 7,109 | $7.54K |
| Joseph C Scodari | Director | 1,385 | $1.47K |
| Jack H Dean | Director | 1,377 | $1.46K |
| James J. Donohue | Director | 1,118 | $1.19K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ACXP quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.